BackPsyence Biomedical Overview

Psyence Biomedical Long Term Debt

Latest long-term debt for PBM: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Psyence Biomedical Long Term Debt History

Loading

Psyence Biomedical vs. peers: Long Term Debt Comparison

Loading

Psyence Biomedical Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Psyence Biomedical (PBM) FAQ

Psyence Biomedical posts a long-term debt of $0 as of September 2025. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Psyence Biomedical's long-term debt was $0. The latest reading is $0 (period ending September 2025). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Psyence Biomedical's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PBM's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Psyence Biomedical's other metric pages and overview cover the third.